The digital health IPO market hasn’t exactly been active in recent years. There was a surge in 2021—21 of the 57 active public digital health companies today made their debut that year on the…
Continue Reading
What You Should Know:
– Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has acquired Deep 6 AI, a leading AI-powered…
Continue Reading
What You Should Know:
– Tempus, a provider of AI-driven precision medicine, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group announced a new collaboration to improve the use of ESR1 testing…
Continue Reading
Welcome to the January edition of Digital Health Digest, your trusted source for the latest in digital health and healthcare technology!In this episode, we cover major updates transforming the digital health landscape—from Bicycle Health…
Continue Reading
Tempus, an AI-powered data company involved in advancing precision medicine, has launched olivia, an AI-enabled personal health concierge app aimed at empowering patients by centralizing patients’ health data and making that data accessible and…
Continue Reading
What You Should Know:
– Tempus AI, a provider of AI-powered precision medicine launches olivia, an innovative personal health concierge app designed to revolutionize how patients manage their health information.
– olivia brings together a patient’s…
Continue Reading
News
Non-profit healthcare safety group ECRI names AI as its top healthcare technology hazard for 2025. Organization President and CEO Marcus Schabacker, MD, PhD said in the list’s announcement, “Balancing innovation in AI with privacy…
Continue Reading
Welcome to a new episode of Digital Health Interviews!Today, we dive into a brutally honest discussion about digital health with our guest, Sergei Polevikov. Sergei brings a wealth of experience and unfiltered insights into…
Continue Reading
What You Should Know:
– Tempus AI, a leader in artificial intelligence (AI)-powered precision medicine, filed with the Securities and Exchange Commission (SEC) on Monday to raise up to $100M in an initial public offering…
Continue Reading
What You Should Know:
– Tempus, a leader in artificial intelligence and precision medicine, announced a groundbreaking data contribution to the National Cancer Institute (NCI) today.
– The first-of-its-kind contribution will significantly enhance the NCI’s planned…
Continue Reading
